Days Set Up
Varies (once per week minimum)
Analytic Time

4-12 days

MiChart Code
HIV-1 DNA and RNA Qualitative Detection by PCR, Plasma (perinatally-expose
Soft Order Code

Test Updated:


HIV-1 DNA by PCR, Diagnostic
HIV-1 DNA by PCR, Qualitative
Human Immunodeficiency Virus DNA by PCR
HIV-1 proviral DNA

Looking to order a test?

We’ve provided helpful links to make ordering easy.

Find a Requisition

All specimens should be accompanied by a requisition.

Submitting Specimens

Learn about how to properly label and where to ship specimens.

Order Kits and Supplies

MLabs provides all the supplies necessary for the collection of specimens.

Test FAQ

Visit our provider FAQ and learn about common questions to ordering tests.

Test Overview

Test Methodology

Real-Time Polymerase Chain Reaction (PCR)

Test Usage

This test is used for virologic detection of HIV-1 infection in infants <18 months of age (an age group for which serologic tests are unreliable) born to HIV-1-infected mothers, early detection of acute HIV-1 infection in children and adults who may be receiving combination antiretroviral prophylaxis or pre-emptive treatment, and determining eradication of HIV-1 in individuals receiving combination highly active antiretroviral therapies.

Reference Range


* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Specimen Requirements

Collection Offsite

Collect specimen in a lavender top tube. Centrifuge, aliquot plasma into a plastic vial within 6 hours of collection, and refrigerate. If shipment will be delayed for >5 days, freeze plasma specimen at -70 C (up to 35 days) until shipment on dry ice.

Lavender Top Tube
Normal Volume
1 mL EDTA plasma
Minimum Volume
0.5 mL EDTA plasma

Billing Information

CPT Code
Pro Fee Code

Have More Questions?

Explore our helpful billing resources:

Our High Standard

Quality that sets us apart

As the reference laboratory division of Michigan Medicine's Department of Pathology, MLabs shares the institution's commitment to applying established quality principles to clinical laboratory testing. Like other large organizations in complex, consequential fields, we rely on an established approach to monitor quality throughout the testing process.